KRISTEN DEEKEN: Open Payments
NPI 1215508346 · BAYVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 45 payments from 8 companies in 2025. Trend: 2023 $208 · 2024 $180 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Alkermes, Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, COBENFY, VIVITROL, FANAPT, REXULTI, SUBLOCADE.
Industry payments across NJ — which companies pay providers there.
